Pharmaceutical rebate contracts, open-house procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
20 / 100
Risk factors
No assurance of any purchase volume; revenue entirely dependent on actual orders from IKK classic
If exclusive discount agreements are concluded for the same active substance, open-house contracts end
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Apr 2028
- Supply of pharmaceutical products (26 active substances) under non-exclusive discount agreements per §130a SGB V
- Performance in Dresden, Germany (DED21)
Show full summary
Open-house non-exclusive discount agreement procedure for pharmaceutical products (26 active substances/lots) by IKK classic. Eligible pharmaceutical entrepreneurs can join at any time until 05.03.2028. No competition, fixed non-negotiable terms. Estimated value not disclosed. Performance in Dresden, Germany.
Risks
No assurance of any purchase volume; revenue entirely dependent on actual orders from IKK classic
If exclusive discount agreements are concluded for the same active substance, open-house contracts end
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per §4 Abs.18 AMG
Administrative
- Submit signed contract, self-declarations, and commercial register extract (not older than 6 months)
- Submission via email or postal mail (no electronic submission allowed)
Requirements may be incomplete.
Buyer
Lots (26)
LOT-0001
Alectinib (ATC: L01ED03)
Alectinib; ATC code L01ED03
Location
Duration
Category
Award details
Alectinib
ATC-Code: L01ED03
Value note
Show original TED data
Original lot title
Alectinib; ATC-Code: L01ED03
Original TED description
Alectinib; ATC-Code: L01ED03
LOT-0002
Amifampridine (ATC: N07XX05)
Amifampridine; ATC code N07XX05
Location
Duration
Category
Award details
Amifampridin
ATC-Code: N07XX05
Value note
Show original TED data
Original lot title
Amifampridin; ATC-Code: N07XX05
Original TED description
Amifampridin; ATC-Code: N07XX05
LOT-0003
Bisacodyl (ATC: A06AB02)
Bisacodyl; ATC code A06AB02
Location
Duration
Category
Award details
Bisacodyl
ATC-Code: A06AB02
Value note
Show original TED data
Original lot title
Bisacodyl; ATC-Code: A06AB02
Original TED description
Bisacodyl; ATC-Code: A06AB02
LOT-0004
Candesartan und Amlodipin; Tabletten; Packungsgröße: 90 Stück; ATC-Code: C09DB07
Candesartan und Amlodipin; Tabletten; Packungsgröße: 90 Stück; ATC-Code: C09DB07
Location
Duration
Category
Award details
Candesartan und Amlodipin
Tabletten
Packungsgröße: 90 Stück
ATC-Code: C09DB07
LOT-0005
Clindamycin und Benzoylperoxid; ATC-Code: D10AF54 (ADV), D10AF51 (WHO)
Clindamycin und Benzoylperoxid; ATC-Code: D10AF54 (ADV), D10AF51 (WHO)
Location
Duration
Category
Award details
Clindamycin und Benzoylperoxid
ATC-Code: D10AF54 (ADV), D10AF51 (WHO)
LOT-0006
Codein; ATC-Code: R05DA04
Codein; ATC-Code: R05DA04
Location
Duration
Category
Award details
Codein
ATC-Code: R05DA04
LOT-0007
Encorafenib; ATC-Code: L01EC03
Encorafenib; ATC-Code: L01EC03
Location
Duration
Category
Award details
Encorafenib
ATC-Code: L01EC03
LOT-0008
Fenoterol und Ipratropiumbromid; ATC-Code: R03AL01
Fenoterol und Ipratropiumbromid; ATC-Code: R03AL01
Location
Duration
Category
Award details
Fenoterol und Ipratropiumbromid
ATC-Code: R03AL01
LOT-0009
Glycopyrroniumbromid; ATC-Code: R03BB06
Glycopyrroniumbromid; ATC-Code: R03BB06
Location
Duration
Category
Award details
Glycopyrroniumbromid
ATC-Code: R03BB06
LOT-0010
Hydroxycarbamid; 100 mg und 1000 mg; ATC-Code: L01XX05
Hydroxycarbamid; 100 mg und 1000 mg; ATC-Code: L01XX05
Location
Duration
Category
Award details
Hydroxycarbamid
100 mg und 1000 mg
ATC-Code: L01XX05
LOT-0011
Imiglucerase; ATC-Code: A16AB02
Imiglucerase; ATC-Code: A16AB02
Location
Duration
Category
Award details
Imiglucerase
ATC-Code: A16AB02
LOT-0012
Interferon beta-1a (Rebif(R)); ATC-Code: L03AB07
Interferon beta-1a (Rebif(R)); ATC-Code: L03AB07
Location
Duration
Category
Award details
Interferon beta-1a (Rebif(R))
ATC-Code: L03AB07
LOT-0013
Lacosamid; Infusionslösung; ATC-Code: N03AX18
Lacosamid; Infusionslösung; ATC-Code: N03AX18
Location
Duration
Category
Award details
Lacosamid
Infusionslösung
ATC-Code: N03AX18
LOT-0014
Moxifloxacin; Augentropfen; ATC-Code: S01AE07
Moxifloxacin; Augentropfen; ATC-Code: S01AE07
Location
Duration
Category
Award details
Moxifloxacin
Augentropfen
ATC-Code: S01AE07
LOT-0015
Nintedanib ; ATC-Code: L01EX09
Nintedanib ; ATC-Code: L01EX09
Location
Duration
Category
Award details
Nintedanib
ATC-Code: L01EX09
LOT-0016
Ribociclib; ATC-Code: L01EF02
Ribociclib; ATC-Code: L01EF02
Location
Duration
Category
Award details
Ribociclib
ATC-Code: L01EF02
LOT-0017
Romiplostim; ATC-Code: B02BX04
Romiplostim; ATC-Code: B02BX04
Location
Duration
Category
Award details
Romiplostim
ATC-Code: B02BX04
LOT-0018
Rufinamid; ATC-Code: N03AF03
Rufinamid; ATC-Code: N03AF03
Location
Duration
Category
Award details
Rufinamid
ATC-Code: N03AF03
LOT-0019
Sirolimus; ATC-Code: L04AH01
Sirolimus; ATC-Code: L04AH01
Location
Duration
Category
Award details
Sirolimus
ATC-Code: L04AH01
LOT-0020
Tafamidis; ATC-Code: N07XX08
Tafamidis; ATC-Code: N07XX08
Location
Duration
Category
Award details
Tafamidis
ATC-Code: N07XX08
LOT-0021
Triptorelin; ATC-Code: L02AE04
Triptorelin; ATC-Code: L02AE04
Location
Duration
Category
Award details
Triptorelin
ATC-Code: L02AE04
LOT-0022
Eculizumab; ATC-Code: L04AJ01
Eculizumab; ATC-Code: L04AJ01
Location
Duration
Category
Award details
Eculizumab
ATC-Code: L04AJ01
LOT-0023
Caspofungin; ATC-Code: J02AX04
Caspofungin; ATC-Code: J02AX04
Location
Duration
Category
Award details
Caspofungin
ATC-Code: J02AX04
LOT-0024
Folsäure; ATC-Code: B03BB01
Folsäure; ATC-Code: B03BB01
Location
Duration
Category
Award details
Folsäure
ATC-Code: B03BB01
LOT-0025
Levomethadon; ATC-Code: N07BC05
Levomethadon; ATC-Code: N07BC05
Location
Duration
Category
Award details
Levomethadon
ATC-Code: N07BC05
LOT-0026
Salmeterol und Fluticason; Inhalationspulver; ATC-Code: R03AK06
Salmeterol und Fluticason; Inhalationspulver; ATC-Code: R03AK06
Location
Duration
Category
Award details
Salmeterol und Fluticason
Inhalationspulver
ATC-Code: R03AK06
Procurement Details
- Publication date
- 19 Apr 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 266413-2026
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
20 / 100
Risk factors
No assurance of any purchase volume; revenue entirely dependent on actual orders from IKK classic
If exclusive discount agreements are concluded for the same active substance, open-house contracts end
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications